OUR PARTNERS

OUR PARTNERS
Resilience is a new biopharmaceutical company, striving to transform the way that drugs and therapies are manufactured through creating a first-of-its-kind ecosystem for advanced biopharmaceutical manufacturing.
They are leveraging innovation, bringing together leading minds in science and engineering with the most advanced technologies to better serve scientific discovery, and reach those in need, a mission aligned with Jameel Health’s own philosophy to build a resilient industry future.
In mid-2021, the JIMCO Life Sciences Fund, the dedicated biotech innovation and venture fund of JIMCO, the Jameel Family’s global investment arm, participated in Reslience’s Series C funding round.
Visit: Resilience
For most of human history, even the tiniest of scratches could prove fatal. Never mind pneumonia, childbirth or surgery, gardening was a potentially deadly pursuit. A graze or scratch could become …
In medical lexicon ‘metabolic syndrome’ (MetS) might not exactly trip from the tongue like ‘heart disease’ or ‘cancer’. Yet, depending on where you live in the world, there could be a …
Forging a new model for cancer treatment: A Q&A with Professor R Charles Coombes, newly appointed special scientific advisor to Jameel Health.
Jameel Health is continually forging partnerships with leading organizations, researchers, innovators and thinkers in the global biotech and health industries. In 2021, it appointed Prof. James J. …
Healthcare – or rather adequate access to it – is one of the biggest challenges facing society today.
Despite the unprecedented levels of global wealth created by economic development over the past century, millions of people across vast regions of our planet are dying unnecessarily through poor …
The COVID-19 pandemic has been a stark reminder – if any were needed – of humankind’s persistent failure to address one of its most enduring, and potentially destabilizing, challenges – …
Health technology is transforming the way we can diagnose, treat and prevent disease, and has the potential to radically improve access to healthcare on a global scale.
From a longer-term historical perspective, the world we live in is undoubtedly fairer than it has ever been versus, say 100 years ago. In many – if not the majority – of countries across the …
Jameel Health appoints three globally respected scientists as special scientific advisors to join its mission in accelerating access to modern medical care across the global south.
©️ 2020-2023, Meddist Company Limited (Jameel Health). All rights in this Site are fully reserved. Permission to use this site is granted strictly subject to the Terms of Use. The Abdul Latif Jameel name, Jameel Health name; the Abdul Latif Jameel and Jameel Health logotypes and pentagon-shaped graphic are trademarks, or registered trademarks of Abdul Latif Jameel IPR Company Limited.
For medical incidence reporting please email: safety@jameelhealth.com or call +971 4 448 0905